Textbook of clinical trials: Difference between revisions
No edit summary |
Tag: Undo |
||
Line 35: | Line 35: | ||
[[Phase III trials|Phase 3 trials]] | [[Phase III trials|Phase 3 trials]] | ||
[[Parallel study|Parallel]] versus | [[Parallel study|Parallel]] versus dose escalation studies | ||
[[Hypothesis|Hypothesis generation]] | [[Hypothesis|Hypothesis generation]] | ||
Line 46: | Line 45: | ||
[[Primary end point|Primary endpoint]] | [[Primary end point|Primary endpoint]] | ||
Secondary endpoints and [[Exploratory research|exploratory endpoints]] | |||
[[Surrogate endpoint|Surrogate endpoints]] | [[Surrogate endpoint|Surrogate endpoints]] |
Revision as of 14:31, 25 October 2019
Ethical Issues Helsinki agreement Investigational Review Board (IRB) HIPAA deidentification and reidentification of patients and patient privacy Regulatory issues and pathways in clinical trials The 1572 form and investigator responsibilities Investigational new drug (IND) application |
Designing Clinical Trials Randomized controlled trials versus observational studies Pharmacokinetic (PK) and pharmcodynamic (PD) assessment Advancing from phase 2 to a phase 3 trial Parallel versus dose escalation studies |
Secondary endpoints and exploratory endpoints Sample size and power calculations Abbreviations used in clinical trials Operationalizing Clinical Trials Principal investigator role Executive committee role Steering committee role Nurse coordinator clinical research associate role |
Monitor role Sponsor role Randomization service Central laboratory facility EKG core laboratory Angiographic core laboratory MRI core laboratory Genetics core laboratory Biomarker core laboratory Identification of sites |
Schedule of events Concomitant medications Clinical event committee or event adjudication committee (CEC) Adverse events, serious adverse events and serious unexpected events Data safety monitoring board (DSMB) Study drug discontinuation, withdrawal of consent, incomplete follow up and lost to follow up patients Protocol adherence Storage and handling of the investigational product |
Data management and designing an electronic data capture form Source documents Study completion and close out Protocol amendments Publication committee Statistical Analysis of Clinical Trials Cleaning a dataset Summary statistics Intent to treat versus modified intent to treat versus as treated Student's t tests and analysis of variance (ANOVA) |
Chi square analysis and Fisher's exact test Handling missing data Subgroup and interaction analyses Net clinical benefit analyses Cost effectiveness analyses Quality adjusted life year analyses Interim analyses and futility analyses Reporting results |
How to write a manuscript Positive publication bias
Study Tools GFR calculationTIMI Risk ScoreGrace Risk Score |